Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T18813 |
Thalidomide-PEG2-C2-NH2
Thalidomide-NH-PEG2-C2-NH2 |
Others | Others |
Thalidomide-O-amido-PEG3-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology[1]. | |||
T18812 |
Thalidomide-PEG2-C2-NH2 TFA
Thalidomide-NH-PEG2-C2-NH2 TFA |
Others | Others |
Thalidomide-O-amido-PEG3-C2-NH2 TFA, a synthesized E3 ligase ligand-linker conjugate, combines the cereblon ligand based on Thalidomide and a 2-unit PEG linker for use in PROTAC technology[1]. | |||
T18811 |
Thalidomide-PEG2-C2-NH2 hydrochloride
Thalidomide-NH-PEG2-C2-NH2 hydrochloride |
Others | Others |
Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate, combines a Thalidomide-based cereblon ligand with a two-unit PEG linker for use in PROTAC technology[1]. |